|
Mar 29
|
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
|
|
Mar 20
|
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
|
|
Mar 13
|
13 Best Biotech Stocks To Buy Under $20
|
|
Mar 7
|
Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD)
|
|
Mar 5
|
Amicus Therapeutics Stock Sees RS Rating Improve To 74
|
|
Jan 12
|
Amicus (FOLD) Stock Rises More Than 25% in 3 Months: Here's Why
|
|
Jan 8
|
Amicus (FOLD) Issues Preliminary Revenue Results for FY23
|
|
Jan 7
|
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
|
|
Jan 6
|
Amicus Therapeutics Inc President and CEO Bradley Campbell Sells 15,833 Shares
|
|
Jan 3
|
15 Best Growth Stocks to Buy Under $25
|
|
Jan 3
|
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 30
|
Even after rising 4.3% this past week, Amicus Therapeutics (NASDAQ:FOLD) shareholders are still down 39% over the past three years
|
|
Dec 29
|
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
|
|
Dec 29
|
Amicus Therapeutics Inc Chief Accounting Officer Sells Company Shares
|
|
Dec 24
|
‘Time to Pull the Trigger,’ Says Morgan Stanley About These 2 Healthcare Stocks
|
|
Dec 21
|
Amicus Therapeutics Inc's Chief Development Officer Sells Shares
|
|
Dec 8
|
Why Is Amicus Therapeutics (FOLD) Up 15% Since Last Earnings Report?
|
|
Dec 5
|
BIO names longtime Amicus head John Crowley as its new CEO
|
|
Dec 5
|
Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO
|
|
Dec 5
|
He Designed Drugs to Save His Children. Now He’s Working to Save Biotech, Too.
|